Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer

By Delpech Y.  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 619-627

Springer Publishing Company

Access to resources Recommend Favorite

Soluble Interleukin-6 Receptor is a Prognostic Marker for Relapse-Free Survival in Estrogen Receptor-Positive Breast Cancer

By Won Hye Sung   Kim Young Ae   Lee Jun Sang   Jeon Eun Kyoung   An Ho Jung   Sun Der Sheng   Ko Yoon Ho   Kim Jeong Soo  

Cancer Investigation, Vol. 31, Iss. 8, 2013-10 ,pp. : 516-521

Informa Healthcare

Access to resources Recommend Favorite

Estrogen receptor positive tumors: Do reproductive factors explain differences in incidence between black and white women?

By Warner Erica   Tamimi Rulla   Boggs Deborah   Rosner Bernard   Rosenberg Lynn   Colditz Graham   Palmer Julie  

Cancer Causes and Control, Vol. 24, Iss. 4, 2013-04 ,pp. : 731-739

Springer Publishing Company

Access to resources Recommend Favorite

Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapy

By              

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 303-308

Spandidos Publications

Access to resources Recommend Favorite

Protein kinase C-α downregulates estrogen receptor-α by suppressing c-Jun phosphorylation in estrogen receptor-positive breast cancer cells

By                    

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1423-1428

Spandidos Publications

Access to resources Recommend Favorite